2016 Annual Report of The Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry

Journal of the American College of Cardiology

Volumn 69, Issue 10, 2017, Pages 1215-1230

  Grover, Frederick L ^a,b   Vemulapalli, Sreekanth ^c   Carroll, John D ^d   Edwards, Fred H ^e   Mack, Michael J ^f   Thourani, Vinod H ^g   Brindis, Ralph G ^h   Shahian, David M ⁱ   Ruiz, Carlos E ^j   Jacobs, Jeffrey P ^k,l   Hanzel, George ^m   Bavaria, Joseph E ⁿ   Tuzcu, E Murat ^o   Peterson, Eric D ^c   Fitzgerald, Susan ^p   Kourtis, Matina ^q   Michaels, Joan ^p   Christensen, Barbara ^p   Seward, William F ^q   Hewitt, Kathleen ^p   Holmes, David R ^r   more..

^a UNIVERSITY OF COLORADO   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF FLORIDA   (United States)

^f SCOTT AND WHITE MEMORIAL HOSPITAL   (United States)

^g EMORY UNIVERSITY   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ MASSACHUSETTS GENERAL HOSPITAL   (United States)

^j HACKENSACK UNIVERSITY MEDICAL CENTER   (United States)

^k JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^l JOHNS HOPKINS ALL CHILDREN S HOSPITAL   (United States)

^m BEAUMONT HOSPITAL   (United States)

ⁿ UNIVERSITY OF PENNSYLVANIA   (United States)

^o HEART AND VASCULAR INSTITUTE   (United Arab Emirates)

^p AMERICAN COLLEGE OF CARDIOLOGY   (United States)

^q The Society of Thoracic Surgeons   (United States)

^r MAYO CLINIC   (United States)

more..

Author keywords

aortic; outcomes; procedural outcomes; procedural risk; transcatheter mitral clip; transcatheter valves; TVT; valve in valve

Indexed keywords

ADULT; AGED; ARTICLE; BLEEDING; CONTROLLED STUDY; FEMALE; HOSPITAL MORTALITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE PROSTHESIS; MITRAL VALVE REGURGITATION; MITRAL VALVE REPLACEMENT; PACEMAKER IMPLANTATION; PATIENT SAFETY; REGISTER; SURGICAL MORTALITY; TRANSCATHETER AORTIC VALVE IMPLANTATION; TREND STUDY; VASCULAR DISEASE; CARDIOLOGY; CLINICAL TRIAL; HEART CATHETERIZATION; HEART VALVE DISEASES; HEART VALVE REPLACEMENT; MEDICAL SOCIETY; MULTICENTER STUDY; ORGANIZATION; PROCEDURES; STATISTICS AND NUMERICAL DATA; THORAX SURGERY; UNITED STATES;

CARDIAC CATHETERIZATION; CARDIOLOGY; CONGRESSES AS TOPIC; HEART VALVE DISEASES; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; REGISTRIES; SOCIETIES, MEDICAL; THORACIC SURGERY; UNITED STATES;

EID: 85014428801     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2016.11.033     Document Type: Article

References (17)

1. 1 Centers for Medicare & Medicaid Services. National coverage determination (NCD) for transcatheter aortic valve replacement (TAVR) (20.32). 2013. Available at: https://www.cms.gov/medicare-coverage-database/details/ncd-details.aspx?NCDId=355&ncdver=1&NCAId=257&ver=4&NcaName=Transcatheter+Aortic+Valve+Replacement+(TAVR)&bc=ACAAAAAACAAAAA%3D%3D&. Accessed August 21, 2016.
2. 2 Rumsfeld, J.S., Holmes, D.R., Stough Gattis, W., et al. Insights from the early experience of the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry. J Am Coll Cardiol 8.3 (2015), 377–381.
3. 3 Centers for Medicare & Medicaid Services. Proposed decision memo for transcatheter mitral valve repair (TMVR) (CAG-00438N). Available at: https://www.cms.gov/medicare-coverage-database/details/nca-proposed-decision-memo.aspx?NCAId=273&NcaName=Transcatheter+Mitral+Valve+(TMV)+Procedures&bc=ACAAAAAAAgAAAA%3D%3D&. Accessed August 21, 2016.
4. 4 U.S. Food and Drug Administration. FDA expands approved use of Sapien artificial heart valve. October 19, 2012. Available at: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm323478.htm. Accessed August 21, 2016.
5. 5 Carroll, J.D., Edwards, F.H., Marinac-Dabic, D., et al. The STS-ACC Transcatheter Valve Therapy National Registry: a new partnership and infrastructure for the introduction and surveillance of medical devices and therapies. J Am Coll Cardiol 62 (2013), 1026–1034.
6. 6 Mack, M.J., Brennan, J.M., Brindis, R.G., et al. Outcomes following transcatheter aortic valve replacement in the U.S. JAMA 310 (2013), 2069–2077.
7. 7 Holmes, D.R., Nishimura, R.A., Grover, F.L., et al. Annual outcomes with transcatheter valve therapy: from the STS/ACC TVT registry. J Am Coll Cardiol 66 (2015), 2813–2823.
8. 8 Holmes, D.R., Matthew, J.B., Rumsfeld, J.S., et al. Clinical outcomes at 1 year following transcatheter aortic valve replacement. JAMA 313 (2015), 1019–1028.
9. 9 Center for Devices and Radiological Health. Strengthening our national system for medical device postmark surveillance update and next steps. 2013. Available at: http://www.fda.gov/downloads/MedicalDevices/Safety/CDRHPostmarketSurveillance/UCM348845.pdf. Accessed July 16, 2016.
10. 10 Carroll, J.D., Shuren, J., Jensen, T.S., et al. Transcatheter valve therapy registry is a model for medical device innovation and surveillance. Health Affairs 34 (2015), 328–334.
11. 11 Walther, T., Hamm, C.W., Schuler, G., et al. Perioperative results and complications in 15,964 transcatheter aortic valve replacements: prospective data from the GARY registry. J Am Coll Cardiol 65 (2015), 2173–2180.
12. 12 Makkar, R.R., Fontana, G., Jilaihawi, H., et al. Possible subclinical leaflet thrombosis in bioprosthetic aortic valves. N Engl J Med 373 (2015), 2015–2024.
13. 13 Gilard, M., Eltchaninoff, H., Donzeau-Gouge, P., et al. Late outcomes of transcatheter aortic valve replacement in high-risk patients. the FRANCE-2 registry. J Am Coll Cardiol 68 (2016), 1637–1647.
14. 14 Sorajja, P., Mack, M., Vemulapalli, S., et al. Initial experience with commercial transcatheter mitral valve repair in the United States. J Am Coll Cardiol 67 (2016), 1129–1140.
15. 15 Eleid, M.F., Cabalka, A.K., Williams, M.R., et al. Percutaneous transvenous transseptal transcatheter valve implantation in failed bioprosthetic mitral valves, ring annuloplasty, and severe mitral annular calcification. J Am Coll Cardiol Intv 9 (2016), 1161–1174.
16. 16 Edwards, F.H., Cohen, D.J., O'Brien, S.M., et al. Development and validation of a risk prediction model for in-hospital mortality after transcatheter aortic valve replacement. JAMA Cardiol 1 (2016), 46–52.
17. 17 O'Brien, S.M., Cohen, D.J., Rumsfeld, J.S., et al. Variation in hospital risk–adjusted mortality rates following transcatheter aortic valve replacement in the United States. A report from the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry. Circ Cardiovasc Qual Outcomes 9 (2016), 560–565.